Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer

Leslie Ballas, Parminder Singh, Seth P. Lerner

Research output: Contribution to journalReview articlepeer-review

Abstract

Radical cystectomy with bilateral pelvic lymphadenectomy and trimodality bladder-sparing therapy or TMT, are both curative options for patients with nonmetastatic muscle invasive bladder cancer. Patients should be afforded the opportunity for a multidisciplinary evaluation with equipoise in discussing these options for eligible patients. We discuss the barriers to broader acceptance and utilization of TMT and encourage support of clinical trials of TMT.

Original languageEnglish (US)
JournalUrologic Oncology: Seminars and Original Investigations
DOIs
StateAccepted/In press - 2020

Keywords

  • Barriers
  • Bladder cancer
  • Chemoradiation
  • Radical cystectomy
  • Trimodality therapy

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint

Dive into the research topics of 'Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer'. Together they form a unique fingerprint.

Cite this